Table 3 Co-occurrence of TTIs serologic markers among the MI positive cases
Variable | Total of MI | Co-occurrence: % (N) | P value | |||||
|---|---|---|---|---|---|---|---|---|
anti-HIV/HBVsAg | anti-HIV/anti-HCV | anti-HIV/anti-TP | HBVsAg/anti-HCV | HBVsAg/anti-TP | anti-HCV/anti-TP | |||
Overall | 65 | 23.07 (15) | 16.92 (11) | 27.70 (18) | 4.61 (3) | 20 (13) | 7.70 (5) | 0.002a |
Age | ||||||||
18–27 years | 25 | 24 (6) | 0 (0) | 36 (9) | 4 (1) | 28 (7) | 8 (2) | 0.001 |
28–37 years | 21 | 33.33 (7) | 19.05 (4) | 28.57 (6) | 0 (0) | 14.29 (3) | 4.76 (1) | 0.014 |
38–47 years | 19 | 10.52 (2) | 36.84 (7) | 15.80 (3) | 10.52 (2) | 15.80 (3) | 10.52 (2) | 0.316 |
P value | 0.567 | 0.139 | 0.008 | 0.122 | 0.679 | 0.196 | 1.000 | |
Residence | ||||||||
Al Douiem | 12 | 25 (3) | 8.33 (1) | 25 (3) | 0 (0) | 41.67 (5) | 0 (0) | 0.025 |
Kosti | 27 | 29.63 (8) | 14.82 (4) | 22.22 (6) | 11.11 (3) | 14.82 (4) | 7.40 (2) | 0.320 |
Rabak | 26 | 15.38 (4) | 23.08 (6) | 34.62 (9) | 0 (0) | 15.38 (4) | 11.54 (3) | 0.017 |
P value | 0.006 | 0.208 | 0.100 | 0.122 | 0.036 | 1.000 | 0.251 | |